Ipsen Biopharmaceuticals, Inc.
Ipsen Biopharmaceuticals, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1929, Ipsen has established itself as a leader in the development of innovative therapies, particularly in oncology, neuroscience, and rare diseases.
The company is renowned for its core products, including Somatuline® and Dysport®, which are distinguished by their unique formulations and targeted delivery mechanisms. Ipsen's commitment to research and development has led to significant milestones, including the expansion of its product portfolio and strategic partnerships that enhance its market position. With a focus on patient-centric solutions, Ipsen continues to achieve notable recognition within the biopharmaceutical sector, driving advancements that improve patient outcomes globally.
+25 vs industry average
Ipsen Biopharmaceuticals, Inc.’s score of 63 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Ipsen Biopharmaceuticals, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Ipsen Biopharmaceuticals, Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Ipsen Biopharmaceuticals, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Ipsen Biopharmaceuticals, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Ipsen S.A.
Carbon Disclosure Project
Inherited from Ipsen S.A.The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Ipsen S.A.RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project